Zobrazit minimální záznam

PD1+CD8+ Cells Are an Independent Prognostic Marker in Patients with Head and Neck Cancer

dc.contributor.authorPokrývková, Barbora
dc.contributor.authorGrega, Marek
dc.contributor.authorKlozar, Jan
dc.contributor.authorVencálek, Ondřej
dc.contributor.authorNunvář, Jaroslav
dc.contributor.authorTachezy, Ruth
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1591
dc.description.abstractHead and neck squamous cell carcinomas (HNSCCs) belong to a group of diverse tumors, which can be induced by infection with human papillomavirus (HPV) or tobacco and alcohol con sumption. The viral etiology of HNSCC relates to better clinical outcomes reflecting a different immune system response. Here, we retrospectively analyzed 97 tissue samples from oral and oropha ryngeal carcinomas associated and non-associated with HPV infection using multispectral fluorescent immunohistochemistry. To evaluate the immune cell infiltration in tumor and stroma compartments, we designed four panels of four to five antibodies. We detected more T lymphocytes in the stroma, compared to the tumor parenchyma. In HPV positive (HPV+ ) in comparison to HPV negative (HPV-) tumors, higher counts of CD3+CD4+ , CD3+CD8+ , PD1+CD4+ , PD1+CD8+ T cells, and ICOS- Treg cells were detected while more ICOS+ Treg cells and CTLA4+CD4+ T cells were observed in HPV- than in HPV+ tumors. The results of the univariate and multivariate analyses confirmed the pre dominant impact of HPV status on prognosis. More importantly, the number of CD8+PD-1+ T cells was identified as an independent factor, influencing the overall and/or disease-specific survival of patients with oral cavity or oropharyngeal carcinomas.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.3390/biomedicines10112794
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titlePD1+CD8+ Cells Are an Independent Prognostic Marker in Patients with Head and Neck Canceren
dcterms.accessRightsembargoedAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2023-12-04T09:10:41Z
dc.subject.keywordhead and neck canceren
dc.subject.keywordPD-1en
dc.subject.keywordsurvivalen
dc.subject.keywordHPVen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/COOP/COOP
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5103
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MZ0/NV/NV17-28055A
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/SVV/SVV260568
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/OP VVV/CZ.02.1.01/0.0/0.0/16_019/0000785
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/EF/EF16_019/0000785
dc.date.embargoStartDate2023-12-04
dc.date.embargoEndDate2022-11-03
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.3390/biomedicines10112794
dc.identifier.utWos000883367500001
dc.identifier.eidScopus2-s2.0-85141827118
dc.identifier.obd617292
dc.identifier.rivRIV/00216208:11130/22:10449633
dc.identifier.rivRIV/00216208:11310/22:10449633
dc.identifier.rivRIV/00216208:11110/22:10449633
dc.identifier.rivRIV/00064203:_____/22:10449633
dc.identifier.pubmed36359314
dc.subject.rivPrimary10000::10600::10607
dc.subject.rivSecondary30000::30200::30204
dcterms.isPartOf.nameBiomedicines
dcterms.isPartOf.issn2227-9059
dcterms.isPartOf.journalYear2022
dcterms.isPartOf.journalVolume10
dcterms.isPartOf.journalIssue11
uk.faculty.primaryId115
uk.faculty.primaryNamePřírodovědecká fakultacs
uk.faculty.primaryNameFaculty of Scienceen
uk.faculty.secondaryId108
uk.faculty.secondaryId109
uk.faculty.secondaryId52
uk.faculty.secondaryName1. lékařská fakultacs
uk.faculty.secondaryNameFirst Faculty of Medicineen
uk.faculty.secondaryName2. lékařská fakultacs
uk.faculty.secondaryNameSecond Faculty of Medicineen
uk.faculty.secondaryNameFakultní nemocnice v Motolecs
uk.faculty.secondaryNameMotol University Hospitalen
uk.department.primaryId1034
uk.department.primaryNameKatedra genetiky a mikrobiologiecs
uk.department.primaryNameDepartment of Genetics and Microbiologyen
uk.department.secondaryId1705
uk.department.secondaryId100010692662
uk.department.secondaryId100010693933
uk.department.secondaryId1471
uk.department.secondaryNameÚstav patologie a molekulární medicínycs
uk.department.secondaryNameÚstav patologie a molekulární medicínyen
uk.department.secondaryNameKlinika otorinolaryngologie a chirurgie hlavy a krku 1. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Otorhinolaryngology and Head and Neck Surgery, 2nd Faculty of Medicine and Motol Univen
uk.department.secondaryNameÚstav patologie a molekulární medicíny 2. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Pathology and Molecular Medicine, 2nd Faculty of Medicine and Motol University Hospiten
uk.department.secondaryNameKlinika otorinolaryngologie a chirurgie hlavy a krku 1. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Otorhinolaryngology, Head and Neck Surgeryen
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitlePD1+CD8+ Cells Are an Independent Prognostic Marker in Patients with Head and Neck Canceren


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam